Sionna Therapeutics Stock Forecast
NASDAQ: SIONHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
SION analyst consensus
Consensus (12 analysts)
hold
Avg. price target
$21.00+328.57%
- Strong buy 0
- Buy 2
- Hold 10
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 12 Wall Street analysts covering Sionna Therapeutics (2026-10-08), 2 rate the stock a buy or strong buy, 10 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "hold". The average 12-month price target is $21.00, with a high estimate of $63.00 and a low estimate of $5.00. The average target implies upside of 328.6% from the current price of $4.90.
The spread between the highest and lowest targets is 1160.0%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for SION.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 0 | 0% |
| Buy | 2 | 17% |
| Hold | 10 | 83% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-08.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $5.00 | +2.04% |
| Average target | $21.00 | +328.57% |
| High target | $63.00 | +1185.71% |